Robert Liu
Managing Director, CDIB Yida Healthcare Private Equity Fund
Achievements
Mr. Liu has extensive experience in M&A deals and investment transactions in the US, Europe and Asia (more than US$3bn in value).
Career Highlights
Principal, Venture Investments
Johnson & Johnson Development Corporation
Director of Business Development & Strategy
GlaxoSmithKline, Greater China
Senior Associate
Charles River Laboratories
The best preparation for tomorrow is doing you best today.
Education & Honors
University of Rochester
PhD in Pharmacology
University of Chicago
MBA at Booth School of Business
Key Experiences
Expertise in Venture Capital & Private Equity Healthcare
Venture capital and private equity investments in life sciences and healthcare in the Asia-Pacific region (Johnson & Johnson Development Corporation (JJDC)) 2013-19.
Joined CDIB in 2019.
Joined CDIB in 2019.
Expertise in M&A and Investment Transactions
Director of Business Development & Strategy in Greater China at GlaxoSmithKline.
Global Corporate Development & Strategy, Charles River Laboratories, Boston, US.
Has executed over US$3bn worth of M&A deals and investment transactions in the US, Europe and Asia.
Global Corporate Development & Strategy, Charles River Laboratories, Boston, US.
Has executed over US$3bn worth of M&A deals and investment transactions in the US, Europe and Asia.
MEET OUR PRESIDENT OF CDIB YIDA PRIVATE EQUITY (KUNSHAN) CO. LTD.
Yen Lu